1. Home
  2. HEES vs MIRM Comparison

HEES vs MIRM Comparison

Compare HEES & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HEES
  • MIRM
  • Stock Information
  • Founded
  • HEES 1961
  • MIRM 2018
  • Country
  • HEES United States
  • MIRM United States
  • Employees
  • HEES N/A
  • MIRM N/A
  • Industry
  • HEES Misc Corporate Leasing Services
  • MIRM Biotechnology: Pharmaceutical Preparations
  • Sector
  • HEES Industrials
  • MIRM Health Care
  • Exchange
  • HEES Nasdaq
  • MIRM Nasdaq
  • Market Cap
  • HEES 2.1B
  • MIRM 1.9B
  • IPO Year
  • HEES 2006
  • MIRM 2019
  • Fundamental
  • Price
  • HEES $56.68
  • MIRM $43.48
  • Analyst Decision
  • HEES Buy
  • MIRM Strong Buy
  • Analyst Count
  • HEES 6
  • MIRM 13
  • Target Price
  • HEES $61.25
  • MIRM $57.00
  • AVG Volume (30 Days)
  • HEES 295.6K
  • MIRM 391.5K
  • Earning Date
  • HEES 10-29-2024
  • MIRM 11-12-2024
  • Dividend Yield
  • HEES 1.95%
  • MIRM N/A
  • EPS Growth
  • HEES N/A
  • MIRM N/A
  • EPS
  • HEES 3.94
  • MIRM N/A
  • Revenue
  • HEES $1,518,307,000.00
  • MIRM $307,028,000.00
  • Revenue This Year
  • HEES $4.55
  • MIRM $73.07
  • Revenue Next Year
  • HEES $3.91
  • MIRM $27.98
  • P/E Ratio
  • HEES $14.36
  • MIRM N/A
  • Revenue Growth
  • HEES 5.69
  • MIRM 112.14
  • 52 Week Low
  • HEES $40.92
  • MIRM $23.14
  • 52 Week High
  • HEES $66.18
  • MIRM $48.89
  • Technical
  • Relative Strength Index (RSI)
  • HEES 54.79
  • MIRM 57.65
  • Support Level
  • HEES $54.51
  • MIRM $40.80
  • Resistance Level
  • HEES $60.66
  • MIRM $44.12
  • Average True Range (ATR)
  • HEES 1.83
  • MIRM 2.42
  • MACD
  • HEES -0.38
  • MIRM 0.15
  • Stochastic Oscillator
  • HEES 61.60
  • MIRM 49.58

About HEES H&E Equipment Services Inc.

H&E Equipment Services Inc is an integrated equipment services company. It is focused on heavy construction and industrial equipment. It rents, sells, and provides parts and services support for four core categories of equipment including hi-lift or aerial work platform equipment, cranes, earthmoving equipment, and industrial lift trucks. It engages in five principal business activities: equipment rentals; new equipment sales; sales of rental equipment; parts sales; and services. The majority of its revenue is derived from the equipment rentals segment.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter "IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: